A detailed history of Ovata Capital Management LTD transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Ovata Capital Management LTD holds 200,000 shares of RCKT stock, worth $2.09 Million. This represents 2.45% of its overall portfolio holdings.

Number of Shares
200,000
Holding current value
$2.09 Million
% of portfolio
2.45%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$11.35 - $18.82 $2.27 Million - $3.76 Million
200,000 New
200,000 $2.51 Million
Q2 2022

Aug 05, 2022

SELL
$7.96 - $16.64 $7,164 - $14,976
-900 Reduced 23.68%
2,900 $40,000
Q4 2021

Feb 14, 2022

BUY
$21.52 - $36.02 $81,776 - $136,876
3,800 New
3,800 $82,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $792M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Ovata Capital Management LTD Portfolio

Follow Ovata Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ovata Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ovata Capital Management LTD with notifications on news.